Krebs Biochemicals & Industries Limited (KREBSBIO.BO)
INR 98.95
(-0.3%)
INR 98.95
(-0.3%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 97.96 Million INR | -17.99% |
| 2022 | 119.45 Million INR | -53.27% |
| 2021 | 255.62 Million INR | 53.99% |
| 2020 | 166 Million INR | 10.7% |
| 2019 | 149.95 Million INR | 67.29% |
| 2018 | 89.63 Million INR | -23.57% |
| 2017 | 117.28 Million INR | 115.01% |
| 2016 | 54.54 Million INR | -3.21% |
| 2015 | 56.35 Million INR | 3.35% |
| 2014 | 54.53 Million INR | 0.0% |
| 2011 | 304.85 Million INR | 3.69% |
| 2010 | 294 Million INR | 0.1% |
| 2009 | 293.71 Million INR | 37.9% |
| 2008 | 212.98 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 97.96 Million INR | -17.99% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 97.96 Million INR | 0.0% |
| 2023 Q2 | 111.46 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 119.45 Million INR | -53.27% |
| 2022 Q2 | 141.88 Million INR | 0.0% |
| 2022 Q4 | 119.45 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 196.4 Million INR | 0.0% |
| 2021 Q4 | 255.62 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 255.62 Million INR | 53.99% |
| 2020 FY | 166 Million INR | 10.7% |
| 2020 Q4 | 166 Million INR | 0.0% |
| 2020 Q2 | 194.52 Million INR | 0.0% |
| 2019 Q4 | 149.95 Million INR | 0.0% |
| 2019 Q2 | 108.07 Million INR | 0.0% |
| 2019 FY | 149.95 Million INR | 67.29% |
| 2018 Q4 | 89.63 Million INR | 0.0% |
| 2018 Q2 | 80.39 Million INR | 0.0% |
| 2018 FY | 89.63 Million INR | -23.57% |
| 2017 Q4 | 117.28 Million INR | 0.0% |
| 2017 Q2 | 66.93 Million INR | 0.0% |
| 2017 FY | 117.28 Million INR | 115.01% |
| 2016 FY | 54.54 Million INR | -3.21% |
| 2016 Q2 | 57.55 Million INR | 0.0% |
| 2016 Q4 | 54.54 Million INR | 0.0% |
| 2015 FY | 56.35 Million INR | 3.35% |
| 2015 Q4 | 56.35 Million INR | 0.0% |
| 2015 Q2 | 63.54 Million INR | 0.0% |
| 2014 FY | 54.53 Million INR | 0.0% |
| 2013 Q3 | 308.24 Million INR | 0.0% |
| 2012 Q2 | 340.99 Million INR | 0.0% |
| 2011 FY | 304.85 Million INR | 3.69% |
| 2011 Q4 | 304.85 Million INR | 0.0% |
| 2010 FY | 294 Million INR | 0.1% |
| 2009 FY | 293.71 Million INR | 37.9% |
| 2008 FY | 212.98 Million INR | 0.0% |
| 2008 Q4 | 212.98 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 98.817% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 66.108% |
| Sigachi Industries Limited | 707.2 Million INR | 86.148% |
| Bal Pharma Limited | 878.11 Million INR | 88.844% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | 6.324% |
| Medico Remedies Limited | 163.37 Million INR | 40.036% |
| Lasa Supergenerics Limited | 190.43 Million INR | 48.558% |
| Venus Remedies Limited | 1.21 Billion INR | 91.95% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | 28.312% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 98.619% |
| Shilpa Medicare Limited | 3.44 Billion INR | 97.16% |
| Aarti Drugs Limited | 4.85 Billion INR | 97.984% |
| Lupin Limited | 49.53 Billion INR | 99.802% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.9% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.715% |
| Windlas Biotech Limited | 621.89 Million INR | 84.247% |
| Suven Life Sciences Limited | 7.08 Million INR | -1282.696% |
| Eris Lifesciences Limited | 1.89 Billion INR | 94.818% |
| Valiant Laboratories Limited | 100.15 Million INR | 2.187% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 98.051% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 97.277% |
| Ipca Laboratories Limited | 24.71 Billion INR | 99.604% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 91.729% |
| Achyut Healthcare Limited | 568 Thousand INR | -17147.183% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.901% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 93.199% |
| RPG Life Sciences Limited | 1.01 Billion INR | 90.301% |
| Mankind Pharma Limited | 15.53 Billion INR | 99.369% |
| Laurus Labs Limited | 18.45 Billion INR | 99.469% |
| Piramal Pharma Limited | 21.75 Billion INR | 99.55% |
| Syncom Formulations (India) Limited | 210.81 Million INR | 53.531% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.57% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.404% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.61% |
| Unichem Laboratories Limited | 7.04 Billion INR | 98.61% |
| Sequent Scientific Limited | 3.46 Billion INR | 97.171% |
| Novartis India Limited | 448.6 Million INR | 78.162% |
| Wanbury Limited | 360.23 Million INR | 72.805% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 95.763% |
| Wockhardt Limited | 6.4 Billion INR | 98.469% |
| Themis Medicare Limited | 705.74 Million INR | 86.119% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 34.678% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 99.24% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 98.53% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.846% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.692% |
| NATCO Pharma Limited | 7 Billion INR | 98.602% |
| Gufic Biosciences Limited | 2 Billion INR | 95.114% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 97.694% |
| Ind-Swift Limited | 640.91 Million INR | 84.715% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 91.022% |
| FDC Limited | 3.88 Billion INR | 97.481% |
| Granules India Limited | 13 Billion INR | 99.247% |
| Medicamen Biotech Limited | 593.75 Million INR | 83.501% |
| Alkem Laboratories Limited | 26.61 Billion INR | 99.632% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 95.701% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -284.218% |
| Brooks Laboratories Limited | 96.1 Million INR | -1.931% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | 87.945% |
| Strides Pharma Science Limited | 11.26 Billion INR | 99.13% |
| Neuland Laboratories Limited | 3.5 Billion INR | 97.204% |
| Morepen Laboratories Limited | 2.48 Billion INR | 96.059% |
| Hikal Limited | 3.03 Billion INR | 96.775% |
| Indoco Remedies Limited | 3.53 Billion INR | 97.225% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 98.476% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -145.647% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 92.077% |
| Hester Biosciences Limited | 755.81 Million INR | 87.039% |